Mon, February 26, 2024

Gregory Renza Maintained (SPRB) at Buy with Increased Target to $9 on, Feb 26th, 2024

Gregory Renza of RBC Capital, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Increased Target from $8 to $9 on, Feb 26th, 2024.

Gregory has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregory


  • Evan Wang of "Guggenheim" Initiated at Strong Buy and Held Target at $10 on, Wednesday, February 21st, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Monday, November 20th, 2023